Skip to Content
Merck
  • In vitro and in vivo investigation of a zonal microstructured scaffold for osteochondral defect repair.

In vitro and in vivo investigation of a zonal microstructured scaffold for osteochondral defect repair.

Biomaterials (2022-05-20)
Joseph A M Steele, Axel C Moore, Jean-Philippe St-Pierre, Seth D McCullen, Adam J Gormley, Conor C Horgan, Cameron Rm Black, Christoph Meinert, Travis Klein, Siamak Saifzadeh, Roland Steck, Jiongyu Ren, Maria A Woodruff, Molly M Stevens
ABSTRACT

Articular cartilage is comprised of zones that vary in architecture, extracellular matrix composition, and mechanical properties. Here, we designed and engineered a porous zonal microstructured scaffold from a single biocompatible polymer (poly [ϵ-caprolactone]) using multiple fabrication strategies: electrospinning, spherical porogen leaching, directional freezing, and melt electrowriting. With this approach we mimicked the zonal structure of articular cartilage and produced a stiffness gradient through the scaffold which aligns with the mechanics of the native tissue. Chondrocyte-seeded scaffolds accumulated extracellular matrix including glycosaminoglycans and collagen II over four weeks in vitro. This prompted us to further study the repair efficacy in a skeletally mature porcine model. Two osteochondral lesions were produced in the trochlear groove of 12 animals and repaired using four treatment conditions: (1) microstructured scaffold, (2) chondrocyte seeded microstructured scaffold, (3) MaioRegen™, and (4) empty defect. After 6 months the defect sites were harvested and analyzed using histology, micro computed tomography, and Raman microspectroscopy mapping. Overall, the scaffolds were retained in the defect space, repair quality was repeatable, and there was clear evidence of osteointegration. The repair quality of the microstructured scaffolds was not superior to the control based on histological scoring; however, the lower score was biased by the lack of histological staining due to the limited degradation of the implant at 6 months. Longer follow up studies (e.g., 1 yr) will be required to fully evaluate the efficacy of the microstructured scaffold. In conclusion, we found consistent scaffold retention, osteointegration, and prolonged degradation of the microstructured scaffold, which we propose may have beneficial effects for the long-term repair of osteochondral defects.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Lubricin/Proteoglycan 4, clone 5C11 Antibody, clone 5C11, from mouse